Trade Mark Journal No.2026/028 10 July 2026

WO0000001924425 (5)

Office of origin: United States of America

Date of International Registration:27 April 2026
Date of designation in the UK: 27 April 2026
Image for mark 1924425 COVRYX

International priority date claimed: 29 October 2025 (United States of America) (99468188)
Class 5
Pharmaceutical preparations for the treatment of infectious diseases; medicinal preparations for the treatment and prevention of cancer and infectious diseases, including coronavirus, for administration as a vaccine; pharmaceutical preparations for the prevention of infectious diseases, including coronavirus, for administration as a vaccine; pharmaceutical preparations for the treatment of cancer, including coronavirus, for administration as a vaccine; pharmaceutical preparations for the prevention of cancer, including coronavirus, for administration as a vaccine; biological preparations for the prevention and treatment of cancer and infectious diseases, including coronavirus, for administration as a vaccine.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA